COMPARE-AMI trial: Comparison of intracoronary injection of CD133 + bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: Study rationale and design

Journal of Cardiovascular Translational Research

Volumn 3, Issue 2, 2010, Pages 153-159

  Mansour, Samer ^a   Roy, Denis Claude ^b   Bouchard, Vincent ^c   Nguyen, Ba Khoi ^a   Stevens, Louis Mathieu ^a   Gobeil, Francois ^a   Rivard, Alain ^a   Leclerc, Guy ^a   Reeves, François ^a   Noiseux, Nicolas ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cellular Therapy; Heart Failure; Myocardial Infarct; Stem Cells

Indexed keywords

CD133 ANTIGEN; PLACEBO; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ACUTE HEART INFARCTION; ADULT; AGED; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BONE MARROW BIOPSY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DOUBLE BLIND PROCEDURE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEMATOPOIETIC STEM CELL; HUMAN; INTRACORONARY INFUSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SAFETY; THERAPY EFFECT; TREATMENT OUTCOME; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CONVALESCENCE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIGENS, CD; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; DOUBLE-BLIND METHOD; FEMALE; GLYCOPROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PEPTIDES; RECOVERY OF FUNCTION; RESEARCH DESIGN; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; ANGIOPLASTY, BALLOON, CORONARY;

EID: 77953615648     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-009-9145-2     Document Type: Review

References (44)

1. Ertl, G., Gaudron, P., & Hu, K. (1993). Ventricular remodeling after myocardial infarction: experimental and clinical studies. Basic Research in Cardiology, 88, 125-137.
2. Pfeffer, M. A. & Braunwald, E. (1990). Ventricular remodeling after myocardial infarction: experimental observation and clinical implications. Circulation, 81, 1161-1172.
3. Towbin, J. A. & Bowles, N. E. (2002). The failing heart. Nature, 415, 227-233.
4. Leor, J., Patterson, M., Quinones, M. J., Kedes, L. H., Kloner, R. A., et al. (1996). Transplantation of fetal myocardial tissue into infarcted myocardium of rat: a potential method for repair of infracted myocardium? Circulation, 94(Suppl II), 332-336.
5. Menasche, P., Hagege, A. A., Scorsin, M., et al. (2001). Myoblast transplantation for heart failure. Lancet, 357, 279-280.
6. Menasche, P., Hgege, A. A., Vilquin, J.-T., Pouzet, B., Desnos, M., Duboc, D., et al. (2003). Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. Journal of the American College of Cardiology, 41, 1078-1083.
7. Murry, C. E., Wiseman, R. W., Schwartz, S. M., Hauschka, S. D., et al. (1996). Skeletal myoblast transplantation for repair of myocardial necrosis. Journal of Clinical Investigation, 98, 2512-2523.
8. Taylor, D. A., Atkins, B. Z., Hungspreugs, P., Jones, T. R., Reedy, M. C., Hutcheson, K. A., et al. (1998). Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nature Medicine, 4, 929-933.
9. Perin, E. C., Geng, Y. J., & Willerson, J. T. (2003). Adult stem cell therapy in perspective. Circulation, 107, 935-938.
10. Siminiak, T. & Kurpisz, M. (2003). Myocardial replacement therapy. Circulation, 108, 1167-1171.
11. Tomita, S., Li, R.-K., Weisel, R. D., Micjke, D. A. G., Kim, E. J., & Sakai, T. (1999). Autologous transplantation of bone marrow cells improve damaged heart function. Circulation, 100(Suppl 1), II 247-II 256.
12. Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J., et al. (2001). Neovascularization of ischemic myocardium by human bone marrow derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Medicine, 7, 430-436.
13. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410, 701-705.
14. Orlic, D., Hill, J. M., & Arai, A. E. (2002). Stem cells for cardiac regeneration. Circulation Research, 91, 1092-1102.
15. Shintani, S., Murohara, T., Ikeda, H., Ueno, T., Honma, T., Katoh, A., et al. (2001). Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation, 103, 2776-2779.
16. Balsam, L. B., Wagers, A. J., Christensen, J. L., Kofidis, T., Weissman, I. L., Robbins, R. C., et al. (2004). Haematopoietic stem cells adopt mature haematopoietic fates in ischemic myocardium. Nature, 428, 668-673.
17. Murry, C. E., Soopa, M. H., Reinecke, H., et al. (2004). Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature, 428, 664-668.
18. Zhang, S., Wang, D., Estrov, Z., Raj, S., Willerson, J. T., Yeh, E. T., et al. (2004). Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation, 110, 3803-3807.
19. Kinnaird, T., Stabile, E., Burnett, S. E., Shou, M., Lee, C. W., Barr, S., et al. (2004). Local delivery of marrow derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation, 109, 1543-1549.
20. Noiseux, N., Gnecchi, M., Lopez-Ilasaca, M., Zhang, L., Solomon, S. D., Deb, A., et al. (2006). Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Molecular Therapy, 14(6), 840-850.
21. Assmus, B., Scharinger, V., Teupe, C., Britten, M., Lehmann, R., Dobert, N., et al. (2002). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCAREAMI). Circulation, 106, 3009-3017.
22. Britten, M., Abolmaali, N. D., Assmus, B., Lehmann, R., Honold, J., Schmitt, J., et al. (2003). Infarct remodeling following intracoronary progenitor cells treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation, 108, 2212-2218.
23. Fernandez-Aviles, F., San Roman, J. A., Garcia-Frade, J., Fernandez, M. E., Penarrubia, M. J., de la Fuente, L., et al. (2004). Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circulation Research, 95, 742-748.
24. Lunde, K., Solheim, S., Aakhus, S., Arnesen, H., Abdelnoor, M., Egeland, T., et al. (2006). Intracoronary injection of mononuclear cells in acute myocardial infarction. New England Journal of Medicine, 355, 1199-1209.
25. Meyer, G. P., Wollert, K. C., Lotz, J., Pirr, J., Rager, U., Lippolt, P., Hahn, A., Fichtner, S., Schaefer, A., Arseniev, L., Ganser, A., & Drexler, H. (2009). Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomizedcontrolled BOOST trial. European Heart Journal, (Sep 22).
26. Schächinger, V., Assmuss, B., Britten, M. B., Honold, J., Lehmann, R., Teupe, C., et al. (2004). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI) 1 year follow-up. JACC, 44(8).
27. Schächinger, V., Erbs, S., Elsässer, A., Haberbosch, W., Hambrecht, R., Holschermann, H., et al. (2006). Intracoronary bone marrowderived progenitor cells in acutemyocardial infarction. New England Journal of Medicine, 355, 1210-1221.
28. Wollert, K. C., Meyer, G. P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., Breidenbach, C., et al. (2004). Intracoronary autologous bone-marrow transfer after myocardial infarction: the BOOST randomized controlled clinical trial. Lancet, 364, 141-148.
29. Abdel-Latif, A., Bolli, R., Tleyjeh, I. M., Montori, V. M., Perin, E. C., Hornung, C. A., et al. (2007). Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Archives of Internal Medicine, 167(10), 989-997.
30. Lipinski, M. J., Biondi-Zoccai, G. G. L., Abbate, A., Khianey, R., Sheiban, I., Bartunek, J., et al. (2007). Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction. JACC, 50, 1761-1767.
31. Martin-Rendon, E., Brunskill, S. J., Hyde, C. J., Stanworth, S. J., Mathur, A., Watt, S. M., et al. (2008). Autologous bone marrow stem cells to treat acute myocardial infarction: a systemic review. European Heart Journal, 29, 1807-1818.
32. Yousef, M., Schannwell, C. M., Köstering, M., Zeus, T., Brehm, M., Strauer, B. E., et al. (2009). The BALANCE study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. Journal of the American College of Cardiology, 53(24), 2262-2269.
33. Menasche, P. (2009). Cell-based therapy for heart disease: A clinically oriented perspective. Molecular Therapy, 17(5), 758-766.
34. Bhatia, M. (2001). AC133 expression in human stem cells. Leukemia, 15, 1685-1688.
35. + cells isolated from cord blood are highly enriched in long term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells, 16, 387-396.
36. - stem cells that give rise to SCIDrepopulating cells. Blood, 101, 869-876.
37. + cells. British Journal of Hematology, 115, 180-194.
38. + bone marrow cells promote cardiac regeneration after acute myocardial infarction. Circulation, 112(Suppl I), I-178-I-183.
39. Dimmeler, S. & Zeiher, A. M. (2009). Cell therapy of acute myocardial infarction: open questions. Cardiology, 113, 155-160.
40. Traverse, J. H. & Henry, T. D. (2008). Cell therapy for acute myocardial infarction-where do we go from here? Journal of Cardiovascular Translational Research, 1, 64-70.
41. Bartunek, J., Sherman, W., Vanderheyden, M., Fernandez-Aviles, F., Wijns, W., & Terzic, A. (2009). Delivery of biologics in cardiovascular regenerative medicine. Clinical Pharmacology and Therapeutics, 85(5), 548-552.
42. Hofmann, M., Wollert, K. C., Meyer, G. P., Menke, A., Arseniev, L., Hertenstein, B., et al. (2005). Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation, 111 (17), 2198-2202.
43. Stamm, C., Westphal, B., Kleine, H. D., Petzsch, M., Kittner, C., Klinge, H., et al. (2003). Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet, 361(9351), 45-46.
44. + progenitors for the repair of infarcted myocardium. Journal of the American College of Cardiology, 44(2), 458-463.